{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:06:51Z","timestamp":1783462011649,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI15\/00856"],"award-info":[{"award-number":["PI15\/00856"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI17\/02233"],"award-info":[{"award-number":["PI17\/02233"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund (ERDF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.coviro.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T06:36:16Z","timestamp":1541658976000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["HDV evolution\u2014will viral resistance be an issue in HDV infection?"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-4084","authenticated-orcid":false,"given":"David","family":"Tabernero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4318-532X","authenticated-orcid":false,"given":"Francisco","family":"Rodriguez-Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2018.10.003_sbref0005","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrgastro.2016.126","article-title":"Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options","volume":"13","author":"Lempp","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0010","first-page":"67","article-title":"RNA editing in hepatitis delta virus","volume":"307","author":"Casey","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/viro.1994.1109","article-title":"Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly","volume":"199","author":"Lee","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/rna.8.2.14238","article-title":"Rolling-circle replication of viroids, viroid-like satellite RNAs and hepatitis delta virus: variations on a theme","volume":"8","author":"Flores","year":"2011","journal-title":"RNA Biol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0025","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2013.11.010","article-title":"Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection","volume":"60","author":"Giersch","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2009.10.036","article-title":"Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D","volume":"52","author":"Schaper","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(92)90756-F","article-title":"Evolution of hepatitis delta virus RNA during chronic infection","volume":"188","author":"Lee","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2013.12.017","article-title":"Conserved features of an RNA promoter for RNA polymerase II determined from sequence heterogeneity of a hepatitis delta virus population","volume":"450\u2013451","author":"Beeharry","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0045","doi-asserted-by":"crossref","first-page":"e0158557","DOI":"10.1371\/journal.pone.0158557","article-title":"Evidence of an exponential decay pattern of the hepatitis delta virus evolution rate and fluctuations in quasispecies complexity in long-term studies of chronic delta infection","volume":"11","author":"Homs","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2018.10.003_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virusres.2017.10.003","article-title":"Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing","volume":"243","author":"Sopena","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid1209.060112","article-title":"Eighth major clade for hepatitis delta virus","volume":"12","author":"Le Gal","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2018.10.003_bib0060","first-page":"173","article-title":"Functional and clinical significance of hepatitis D virus genotype II infection","volume":"307","author":"Wu","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbagrm.2012.09.003","article-title":"RNA polymerase II transcription: structure and mechanism","volume":"1829","author":"Liu","year":"2013","journal-title":"Biochim Biophys Acta - Gene Regul Mech"},{"key":"10.1016\/j.coviro.2018.10.003_bib0070","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/oxfordjournals.molbev.a026075","article-title":"Recombination of hepatitis D virus RNA sequences and its implications","volume":"16","author":"Wu","year":"1999","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/emboj\/21.1.157","article-title":"In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase","volume":"21","author":"Chang","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2018.10.003_bib0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2443.2007.01094.x","article-title":"Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity","volume":"12","author":"Yamaguchi","year":"2007","journal-title":"Genes Cells"},{"key":"10.1016\/j.coviro.2018.10.003_bib0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2015.03.011","article-title":"Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection","volume":"63","author":"Giersch","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.01891-17","article-title":"Amino acid substitutions within HLA-B*27-restricted T cell epitopes prevent recognition by hepatitis delta virus-specific CD8+ T cells","volume":"92","author":"Karimzadeh","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0095","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1128\/jvi.66.11.6641-6648.1992","article-title":"Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen","volume":"66","author":"Xia","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0100","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1093\/nar\/21.18.4193","article-title":"Mutagenesis analysis of a hepatitis delta virus genomic ribozyme","volume":"21","author":"Wu","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coviro.2018.10.003_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0110","first-page":"967","article-title":"Standard and pegylated interferon therapy of HDV infection: a systematic review and meta- analysis","volume":"17","author":"Alavian","year":"2012","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.coviro.2018.10.003_bib0115","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1478-3231.2011.02593.x","article-title":"Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment","volume":"31","author":"Grabowski","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.coviro.2018.10.003_bib0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gutjnl-2014-306767","article-title":"Effects of HDV infection and pegylated interferon \u03b1 treatment on the natural killer cell compartment in chronically infected individuals","volume":"64","author":"Lunemann","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.10.006","article-title":"HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes","volume":"136","author":"Alfaiate","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2018.10.003_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2017.05.010","article-title":"A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-\u03b2 induction","volume":"67","author":"Su\u00e1rez-Amar\u00e1n","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.coviro.2018.10.003_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2018.02.021","article-title":"Hepatitis D virus replication is sensed by MDA5 and induces IFN-\u03b2\/\u03bb responses in hepatocytes","volume":"69","author":"Zhang","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0140","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1099\/vir.0.011239-0","article-title":"Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha\/beta interferon-inducible MxA gene","volume":"90","author":"Williams","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.virol.2016.03.017","article-title":"Viral quasispecies complexity measures","volume":"493","author":"Gregori","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0150","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jac\/dkg490","article-title":"Prenylation inhibitors: a novel class of antiviral agents","volume":"52","author":"Einav","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coviro.2018.10.003_bib0155","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.76.20.10465-10472.2002","article-title":"A prenylation inhibitor prevents production of infectious hepatitis delta virus particles","volume":"76","author":"Bordier","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI17704","article-title":"In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus","volume":"112","author":"Bordier","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2018.10.003_bib0165","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(15)00074-2","article-title":"Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial","volume":"15","author":"Koh","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2018.10.003_bib0170","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.29658","article-title":"Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study","volume":"67","author":"Yurdaydin","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0175","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jhep.2016.02.011","article-title":"Entry of hepatitis B and hepatitis D virus into hepatocytes: basic insights and clinical implications","volume":"64","author":"Li","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"L\u00fctgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0190","first-page":"1","article-title":"Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo","volume":"0","author":"Giersch","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.coviro.2018.10.003_bib0195","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3748\/wjg.v24.i6.680","article-title":"Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population","volume":"24","author":"Casillas","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2018.10.003_sbref0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2016.07.004","article-title":"Nucleic acid polymers: broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","volume":"133","author":"Vaillant","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2018.10.003_bib0205","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0210","doi-asserted-by":"crossref","first-page":"JVI.01416","DOI":"10.1128\/JVI.01416-17","article-title":"Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro","volume":"92","author":"Beilstein","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0179697","article-title":"Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes","volume":"12","author":"Guillot","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2018.10.003_bib0220","doi-asserted-by":"crossref","first-page":"33058","DOI":"10.1074\/jbc.M200613200","article-title":"The double-stranded RNA-activated kinase, PKR, can phosphorylate hepatitis D virus small delta antigen at functional serine and threonine residues","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2018.10.003_bib0225","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/JVI.02083-09","article-title":"Phosphorylation of Serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II","volume":"84","author":"Hong","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2017.02.008","article-title":"A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection","volume":"141","author":"Buchmann","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2018.10.003_bib0235","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0032-1323631","article-title":"Perspectives for a vaccine against hepatitis delta virus","volume":"32","author":"Roggendorf","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.coviro.2018.10.003_bib0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jinorgbio.2013.03.002","article-title":"High affinity of copper(II) towards amoxicillin, apramycin and ristomycin. Effect of these complexes on the catalytic activity of HDV ribozyme","volume":"124","author":"Stokowa-So\u0142tys","year":"2013","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.coviro.2018.10.003_bib0245","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1006\/jmbi.1996.0369","article-title":"Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics","volume":"1","author":"Rogers","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-2432-5_2","article-title":"Recent advances in use of gene therapy to treat hepatitis B virus infection","volume":"848","author":"Bloom","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0255","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.3748\/wjg.v21.i32.9461","article-title":"Management of hepatitis delta: need for novel therapeutic options","volume":"21","author":"Abbas","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0260","first-page":"13","article-title":"Inhibitory effect of replication and expression of HDV by antisense oligodeoxynucleotides in H1 delta 9 cell","volume":"7","author":"Li","year":"1999","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.coviro.2018.10.003_bib0265","doi-asserted-by":"crossref","first-page":"749","DOI":"10.6026\/97320630008749","article-title":"Design of potential siRNA molecules for hepatitis delta virus gene silencing","volume":"8","author":"Singh","year":"2012","journal-title":"Bioinformation"},{"key":"10.1016\/j.coviro.2018.10.003_bib0270","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3748\/wjg.v24.i19.2095","article-title":"Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy","volume":"24","author":"Gonz\u00e1lez","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0275","doi-asserted-by":"crossref","first-page":"JVI.02120","DOI":"10.1128\/JVI.02120-17","article-title":"CD8+ T-cell response-associated evolution of hepatitis B virus core protein and disease progress","volume":"92","author":"Zhang","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0280","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.24541","article-title":"HLA-B27 selects for rare escape mutations that significantly impair hepatitis c virus replication and require compensatory mutations","volume":"54","author":"Neumann-Haefelin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2018.10.003_bib0285","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1099\/vir.0.000148","article-title":"Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals","volume":"96","author":"Setiawan","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.10.003_bib0290","doi-asserted-by":"crossref","first-page":"JVI.00017","DOI":"10.1128\/JVI.00017-18","article-title":"Within-host variations of human papillomavirus reveal apobec signature mutagenesis in the viral genome","volume":"92","author":"Hirose","year":"2018","journal-title":"J Virol"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:02:18Z","timestamp":1761818538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625718300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":58,"alternative-id":["S1879625718300221"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2018.10.003","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDV evolution\u2014will viral resistance be an issue in HDV infection?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}